Intrinsic Edge Capital Management LLC Castle Biosciences Inc Transaction History

Intrinsic Edge Capital Management LLC

$782 Million
Q3 2024

A detailed history of Intrinsic Edge Capital Management LLC transactions in Castle Biosciences Inc stock. As of the latest transaction made, Intrinsic Edge Capital Management LLC holds 212,711 shares of CSTL stock, worth $6.56 Million. This represents 0.78% of its overall portfolio holdings.

Number of Shares

212,711

Previous 254,411 16.39%

Holding current value

$6.56 Million

Previous $5.54 Million 9.53%

% of portfolio

0.78%

Previous 0.53%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$17.4 - $31.47 $725,579 - $1.31 Million	-41,700 Reduced 16.39%	212,711 $6.07 Million
Q2 2024 Aug 14, 2024	BUY	$18.84 - $24.94 $581,100 - $769,249	30,844 Added 13.8%	254,411 $5.54 Million
Q1 2024 May 14, 2024	SELL	$18.06 - $25.3 $1.85 Million - $2.6 Million	-102,703 Reduced 31.48%	223,567 $4.95 Million
Q4 2023 Feb 14, 2024	BUY	$12.19 - $22.43 $2.07 Million - $3.81 Million	170,000 Added 108.79%	326,270 $7.04 Million
Q3 2023 Nov 14, 2023	SELL	$13.28 - $20.3 $2.66 Million - $4.06 Million	-199,936 Reduced 56.13%	156,270 $2.64 Million
Q2 2023 Aug 14, 2023	SELL	$11.66 - $26.0 $462,085 - $1.03 Million	-39,630 Reduced 10.01%	356,206 $4.89 Million
Q1 2023 May 15, 2023	BUY	$19.47 - $28.49 $601,019 - $879,457	30,869 Added 8.46%	395,836 $8.99 Million
Q4 2022 Feb 14, 2023	BUY	$18.08 - $30.0 $950,411 - $1.58 Million	52,567 Added 16.83%	364,967 $8.59 Million
Q3 2022 Nov 14, 2022	BUY	$22.51 - $34.32 $675,300 - $1.03 Million	30,000 Added 10.62%	312,400 $8.15 Million
Q2 2022 Aug 15, 2022	BUY	$16.0 - $45.99 $1.12 Million - $3.22 Million	70,000 Added 32.96%	282,400 $6.2 Million
Q1 2022 May 16, 2022	BUY	$33.17 - $46.98 $7.05 Million - $9.98 Million	212,400 New	212,400 $9.53 Million
Q4 2021 Feb 14, 2022	SELL	$39.06 - $67.58 $5.78 Million - $9.99 Million	-147,895 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$60.13 - $77.6 $1.33 Million - $1.71 Million	-22,070 Reduced 12.99%	147,895 $9.84 Million
Q2 2021 Aug 16, 2021	BUY	$50.07 - $76.78 $6.51 Million - $9.98 Million	129,965 Added 324.91%	169,965 $12.5 Million
Q1 2021 May 17, 2021	BUY	$58.92 - $97.33 $2.36 Million - $3.89 Million	40,000 New	40,000 $2.74 Million

Others Institutions Holding CSTL

# of Institutions

200

Shares Held

25.9M

Call Options Held

292K

Put Options Held

30.3K

View Full List

About CASTLE BIOSCIENCES INC

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $811M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

More about CSTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Intrinsic Edge Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intrinsic Edge Capital Management LLC with notifications on news.

Account

Intrinsic Edge Capital Management LLC Castle Biosciences Inc Transaction History